Dr Reddys Laboratories (RDY) Receivables Refunds: 2018-2023
- Dr Reddys Laboratories' Receivables Refunds fell 37.74% to $33.0 million in Q1 2023 from the same period last year, while for Mar 2023 it was $33.0 million, marking a year-over-year decrease of 37.74%. This contributed to the annual value of $33.0 million for FY2023, which is 37.74% down from last year.
- According to the latest figures from Q1 2023, Dr Reddys Laboratories' Receivables Refunds is $33.0 million, which was down 37.74% from $53.0 million recorded in Q1 2022.
- Dr Reddys Laboratories' Receivables Refunds' 5-year high stood at $58.0 million during Q1 2020, with a 5-year trough of $33.0 million in Q1 2023.
- Moreover, its 3-year median value for Receivables Refunds was $38.0 million (2021), whereas its average is $41.3 million.
- Per our database at Business Quant, Dr Reddys Laboratories' Receivables Refunds spiked by 39.47% in 2022 and then slumped by 37.74% in 2023.
- Over the past 5 years, Dr Reddys Laboratories' Receivables Refunds (Quarterly) stood at $49.0 million in 2019, then grew by 18.37% to $58.0 million in 2020, then crashed by 34.48% to $38.0 million in 2021, then surged by 39.47% to $53.0 million in 2022, then plummeted by 37.74% to $33.0 million in 2023.
- Its Receivables Refunds was $33.0 million in Q1 2023, compared to $53.0 million in Q1 2022 and $38.0 million in Q1 2021.
